Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 25 results.
User Information
Export Records
  1. 1.   Abundant binary promoter switches in lineage-determining transcription factors indicate a digital component of cell fate determination
  2. Li,Hongchuan; Rahman, Md Ahasanur; Ruesch, Michael; Eisele, Caprice D; Anderson,Erik; Wright,Paul; Cao, Jennie; Ratnayake, Shashikala; Chen, Qingrong; Yan, Chunhua; Meerzaman, Daoud; Abraham, Roshini S; Freud, Aharon G; Anderson,Steve
  3. Cell Reports. 2023, Nov 16; 42(11): 113454.
  1. 2.   Antisense transcription from lentiviral gene targeting linked to an integrated stress response in colorectal cancer cells
  2. Ha, Taekyu; DiPrima, Michael; Koparde,Vishal; Jailwala,Parthav; Ohnuki, Hidetaka; Feng, Jing-Xin; Palangat, Murali; Larson, Daniel; Tosato, Giovanna
  3. Molecular Therapy. Nucleic Acids. 2022, Jun 14; 28: 877-891.
  1. 3.   Structural Studies Reveal the Role of Helix 68 in the Elongation Step of Protein Biosynthesis
  2. Cimicata, Giuseppe; Fridkin, Gil; Bose, Tanaya; Eyal, Zohar; Halfon, Yehuda; Breiner-Goldstein, Elinor; Fox,Tara; Zimmerman, Ella; Bashan, Anat; de Val, Natalia; Wlodawer,Alexander; Yonath, Ada
  3. mBio. 2022, Mar 29; 13(2): e0030622.
  1. 4.   Targeting the Oncogenic Long Non-coding RNA SLNCR1 by Blocking Its Sequence-Specific Binding to the Androgen Receptor
  2. Schmidt, Karyn; Weidmann, Chase A; Hilimire, Thomas A; Yee, Elaine; Hatfield, Breanne M; Schneekloth,Jay; Weeks, Kevin M; Novina, Carl D
  3. Cell reports. 2020, Jan 14; 30(2): 541-554.e5.
  1. 5.   Antisense Inhibitors Retain Activity in Pulmonary Models of Burkholderia Infection
  2. Daly, Seth M.; Sturge, Carolyn R.; Batty, Kimberly; Felder-Scott, Christina F.; Jain, Raksha; Geller, Bruce L.; Greenberg, David E.
  3. ACS INFECTIOUS DISEASES. 2018, May; 4(5): 806-814.
  1. 6.   Inhibition of Pseudomonas aeruginosa by Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers
  2. Howard, James J.; Sturge, Carolyn R.; Moustafa, Dina A.; Daly, Seth M.; Batty, Kimberly; Felder, Christina F.; Zamora, Danniel; Yabe-Gill, Marium; Labandeira-Rey, Maria; Bailey, Stacey M.; Wong, Michael; Goldberg, Joanna B.; Geller, Bruce L.; Greenberg, David E.
  3. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2017, Apr; 61(4):
  1. 7.   Stabilization of ribozyme-like cis-noncoding rRNAs induces apoptotic and nonapoptotic death in lung cells
  2. Gee, M.; Gu, Y.; Fields, J. R.; Shiao, Y. H.
  3. Cell Death & Disease. 2012, Mar; 3
  1. 8.   Non-coding rRNA-mediated preferential killing in cancer cells is enhanced by suppression of autophagy in non-transformed counterpart
  2. Hwang, C. J.; Fields, J. R.; Shiao, Y. H.
  3. Cell Death & Disease. 2011, Dec; 2
  1. 9.   Killer Immunoglobulin-Like Receptor Transcriptional Regulation: A Fascinating Dance of Multiple Promoters
  2. Cichocki, F.; Miller, J. S.; Anderson, S. K.
  3. Journal of Innate Immunity. 2011, Apr; 3(3): 242-248.
  1. 10.   Quantitative Analysis of MAP-Mediated Regulation of Microtubule Dynamic Instability In Vitro-Focus on Tau
  2. Kiris, E.; Ventimiglia, D.; Feinstein, S. C.
  3. Methods in cell biology. 2010; 95 : 481-503.
  1. 11.   Identification and analysis of novel transcripts and promoters in the human killer cell immunoglobulin-like receptor (KIR) genes
  2. Li, H.; Wright, P. W.; Anderson, S. K.
  3. Methods in molecular biology (Clifton, N.J.). 2010 612: 377-91.
  1. 12.   Small membrane proteins found by comparative genomics and ribosome binding site models
  2. Hemm, M. R.; Paul, B. J.; Schneider, T. D.; Storz, G.; Rudd, K. E.
  3. Molecular Microbiology. 2008 70(6): 1487-1501.
  1. 13.   Host responses influence on the induction of lambda prophage
  2. Rokney, A.; Kobiler, O.; Amir, A.; Court, D. L.; Stavans, J.; Adhya, S.; Oppenheim, A. B.
  3. Molecular Microbiology. 2008 68(1): 29-36.
  1. 14.   Antisense treatments for biothreat agents
  2. Warfield, K. L.; Panchal, R. G.; Aman, M. J.; Bavari, S.
  3. Current Opinion in Molecular Therapeutics. 2006, Apr; 8(2): 93-103.
  1. 15.   Prelamin A and lamin A appear to be dispensable in the nuclear lamina
  2. Fong, L. G.; Ng, J. K.; Lammerding, J.; Vickers, T. A.; Meta, M.; Cote, N.; Gavino, B.; Qiao, X.; Chang, S. Y.; Young, S. R.; Yang, S. H.; Stewart, C. L.; Lee, R. T.; Bennett, C. F.; Bergo, M. O.; Young, S. G.
  3. Journal of Clinical Investigation. 2006, MAR; 116(3): 743-752.
  1. 16.   VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice
  2. Enterlein, S.; Warfield, K. L.; Swenson, D. L.; Stein, D. A.; Smith, J. L.; Gamble, C. S.; Kroeker, A. D.; Iversen, P. L.; Bavari, S.; Muhlberger, E.
  3. Antimicrobial Agents and Chemotherapy. 2006, Mar; 50(3): 984-993.
  1. 17.   Human immunodeficiency virus type 1-induced macrophage gene expression includes the p21 gene, a target for viral regulation
  2. Vazquez, N.; Greenwell-Wild, T.; Marinos, N. J.; Swaim, W. D.; Nares, S.; Ott, D. E.; Schubert, U.; Henklein, P.; Orenstein, J. M.; Sporn, M. B.; Wahl, S. M.
  3. Journal of Virology. 2005 79(7): 4479-4491.
  1. 18.   Switches in bacteriophage lambda development
  2. Oppenheim, A. B.; Kobiler, O.; Stavans, J.; Court, D. L.; Adhya, S.
  3. Annual Review of Genetics. 2005 39: 409-429.
  1. 19.   Getting back on track, or what to do when apoptosis is de-railed - Recoupling oncogenes to the apoptotic machinery
  2. Fearnhead, H. O.
  3. Cancer Biology & Therapy. 2004 3(1): 21-28.
  1. 20.   Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP- 1 transactivation
  2. Yang, H. S.; Knies, J. L.; Stark, C.; Colburn, N. H.
  3. Oncogene. 2003 22(24): 3712-3720.
  1. 21.   Direct and indirect contributions of RNA secondary structure elements to the initiation of HIV-1 reverse transcription
  2. Goldschmidt, V.; Rigourd, M.; Ehresmann, C.; Le Grice, S. F. J.; Ehresmann, B.; Marquet, R.
  3. Journal of Biological Chemistry. 2002 277(45): 43233-43242.
  1. 22.   Inactivation of human O-6-alkylguanine-DNA alkyltransferase by modified oligodeoxyribonucleotides containing O-6-benzylguanine
  2. Pegg, A. E.; Goodtzova, K.; Loktionova, N. A.; Kanugula, S.; Pauly, G. T.; Moschel, R. C.
  3. Journal of Pharmacology and Experimental Therapeutics. 2001 296(3): 958-965.
  1. 23.   Dysfunctional LAD-1 neutrophils and colitis
  2. Uzel, G.; Kleiner, D. E.; Kuhns, D. B.; Holland, S. M.
  3. Gastroenterology. 2001 121(4): 958-964.
  1. 24.   Discovery of small-molecule inhibitors of bcl-2 through structure-based computer screening
  2. Enyedy, I. J.; Ling, Y.; Nacro, K.; Tomita, Y.; Wu, X. H.; Cao, Y. Y.; Guo, R. B.; Li, B. H.; Zhu, X. F.; Huang, Y.; Long, Y. Q.; Roller, P. P.; Yang, D. J.; Wang, S. M.
  3. Journal of Medicinal Chemistry. 2001 44(25): 4313-4324.
  1. 25.   Identification and Characterization of a Cell Membrane Nucleic Acid Channel
  2. Hanss, B.; Lealpinto, E.; Bruggeman, L. A.; Copeland, T. D.; Klotman, P. E.
  3. Proceedings of the National Academy of Sciences of the United States of America. 1998 95(4): 1921-1926.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel